Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
500.00    0.60 (0.12%)
Bid:
498.00
Ask:
500.50
Spread: 2.50 (0.502%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

POST-CLOSE STATEMENT

25 Nov 2014 07:00

RNS Number : 8730X
Chemring Group PLC
25 November 2014
Β 

ο»Ώ

FOR IMMEDIATE RELEASE 25 NOVEMBER 2014

Β 

Β 

CHEMRING GROUP PLC

Β 

POST-CLOSE STATEMENT

Β 

Chemring Group PLC ("Chemring" or "the Group") today provides its scheduled post-close statement in respect of the year ended 31 October 2014.

Β 

Trading

Β 

The Board's expectations for the Group's trading performance for the year ended 31Β October 2014 remain in line with guidance given in the Interim Management Statement issued on 17 September 2014.

Β 

Revenue from continuing operations in the final quarter was approximately Β£117 million, and was impacted by delays in the shipment of product from the Countermeasures facility at Kilgore, following the incident that occurred in February. For the year to 31 October 2014, revenue was approximately Β£475 million (2013: Β£624.9 million) and revenue from continuing operations was approximately Β£403 million (2013: Β£472.3 million).

Β 

The Group's order book at 31 October 2014 was approximately Β£486 million, an increase of Β£68 million since 31 July 2014. As expected, significant orders from US and Middle East customers have been received, including an order for the Husky Mounted Detection Systems ground penetrating radar product for supply into the Middle East.

Β 

Financial position

Β 

At 31 October 2014, net debt was approximately Β£136 million (2013: Β£248.7 million).

Β 

The results for the year ended 31Β OctoberΒ 2014 are due to be announced on 22 January 2015.

Β 

Β 

-ENDS-

Β 

For further information:

Β 

Michael Flowers Group Chief Executive, Chemring Group PLC 01794 833901

Steve Bowers Group Finance Director, Chemring Group PLC 01794 833901

Rupert Pittman Group Director of Communications and 01794 833901

Β Investor Relations, Chemring Group PLC

Β 

James White MHP Communications 0203 128 8100

Β 

Cautionary statement

Β 

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

Β 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

Β 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

Β 

Notes to editors

Β 

Β· Chemring is a global business that specialises in the manufacture of high technology products and services to the aerospace, defence and security markets

Β· Employing approximately 3,000 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries worldwide

Β· Chemring is now organised under three strategic product segments: Countermeasures, Sensors & Electronics, and Energetic Systems

Β· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, mission and information against constantly changing threats

Β· Operating in niche markets and with strong investment in research and development, Chemring has the agility to rapidly react to urgent customer needs

Β 

Β 

www.chemring.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRPGGWAGUPCPUC
Date   Source Headline
1st Sep 20169:05 amRNSTotal Voting Rights
31st Aug 20167:00 amRNSQ3 UPDATE
25th Aug 20163:32 pmRNSHolding(s) in Company
17th Aug 201611:31 amRNSHolding(s) in Company
12th Aug 20169:34 amRNSDirector/PDMR Shareholding
3rd Aug 20169:43 amRNSTotal Voting Rights
28th Jul 201612:29 pmRNSDirector/PDMR Shareholding
22nd Jul 201610:07 amRNSHolding(s) in Company
21st Jul 20167:00 amRNSContract Win
18th Jul 20163:41 pmRNSHolding(s) in Company
4th Jul 20162:22 pmRNSHolding(s) in Company
1st Jul 20169:50 amRNSTotal Voting Rights
29th Jun 20167:00 amRNSDirectorate Change
28th Jun 20169:20 amRNSHolding(s) in Company
23rd Jun 201611:21 amRNSHolding(s) in Company
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
21st Jun 20161:12 pmRNSDirector/PDMR Shareholding
21st Jun 20167:00 amRNSINTERIM RESULTS
20th Jun 20162:39 pmRNSBlock listing Interim Review
20th Jun 20162:37 pmRNSBlock listing Interim Review
1st Jun 201611:01 amRNSTotal Voting Rights
17th May 20167:00 amRNSDirectorate Change
10th May 20164:20 pmRNSDirector/PDMR Shareholding
5th May 20167:00 amRNSCompletion of Acquisition
3rd May 201610:08 amRNSTotal Voting Rights
27th Apr 20162:13 pmRNSDirectorate Change
25th Apr 20169:52 amRNSDirector/PDMR Shareholding
19th Apr 20167:00 amRNSAPPOINTMENT OF CHAIRMAN-DESIGNATE
6th Apr 20164:15 pmRNSDirector/PDMR Shareholding
4th Apr 20167:00 amRNSContract Update
1st Apr 20169:48 amRNSTotal Voting Rights
24th Mar 201610:36 amRNSHolding(s) in Company
21st Mar 20162:05 pmRNSResult of AGM
21st Mar 201611:00 amRNSAGM Trading Update
8th Mar 20162:36 pmRNSDirector/PDMR Shareholding
7th Mar 20167:00 amRNSAPPOINTMENT OF NON-EXECUTIVE DIRECTOR
1st Mar 20165:26 pmRNSCorrection Re Holding in Company
1st Mar 20161:24 pmRNSTotal Voting Rights
26th Feb 201610:23 amRNSHolding(s) in Company
24th Feb 20168:48 amRNSResult of Rump Placing
23rd Feb 20163:03 pmRNSResults of Rights Issue
23rd Feb 201612:40 pmRNSHolding(s) in Company
19th Feb 20163:13 pmRNSDirector/PDMR Shareholding
9th Feb 20168:07 amRNSAdmission of Nil Paid Rights
8th Feb 201611:52 amRNSResult of EGM
4th Feb 201611:26 amRNSDirector/PDMR Shareholding
4th Feb 201611:25 amRNSDirector/PDMR Shareholding
1st Feb 201611:18 amRNSTotal Voting Rights
27th Jan 20167:00 amRNSDirector/PDMR Shareholding
21st Jan 20163:30 pmRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.